Correlation Between Madrigal Pharmaceuticals and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Qualigen Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Qualigen Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Qualigen Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Madrigal and Qualigen is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Qualigen Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.68 times more return on investment than Qualigen Therapeutics. However, Madrigal Pharmaceuticals is 1.47 times less risky than Qualigen Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 24,872 in Madrigal Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 8,802 from holding Madrigal Pharmaceuticals or generate 35.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Qualigen Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Qualigen Therapeutics |
Madrigal Pharmaceuticals and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Qualigen Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |